Literature DB >> 29036623

Predictors of mortality in high-risk patients with QT prolongation in a community hospital.

Charlotte Gibbs1,2, Jacob Thalamus1, Kristian Heldal1,2, Øystein Lunde Holla3, Kristina H Haugaa2,4, Jan Hysing1.   

Abstract

Aims: To determine predictors of mortality in patients with corrected QT interval (QTc) ≥ 500 ms in a community hospital. Methods and results: In this retrospective observational study, we searched the electrocardiogram (ECG) database at Telemark Hospital Trust, Norway, from January 2004 to December 2014. Medication, electrolyte abnormalities, and medical conditions known to prolong the QT interval were recorded. From the medical records, we assessed whether the prolonged QTc was noted by the health care providers. We identified 1531 patients (age = 70 ± 15 years, 59% female) with an ECG with QTc ≥ 500 ms. All-cause mortality during 952 (range 0-4161) days of follow-up was 50% (n =  765/1531). Main predictors of mortality were aborted cardiac arrest [hazard ratio (HR) 2.40, 95% confidence interval (CI) 1.44-4.01; P = 0.001], cerebral stroke/head trauma (HR 2.28, 95% CI 1.70-3.05; P < 0.001), and heart failure (HR 1.74, 95% CI 1.43-2.12; P< 0.001). Females with prolonged QTc had better survival compared with males (P = 0.006). We constructed a risk-weighted QTc mortality score. QT prolongation was acknowledged in the medical records in 12% of the cases. Conclusions: QTc ≥ 500 ms was associated with high all-cause mortality with increased mortality in males compared with females. A new QTc mortality score was constructed to predict mortality. Only a minority of cases with prolonged QTc ≥ 500 ms were acknowledged in the medical records.

Entities:  

Mesh:

Year:  2018        PMID: 29036623     DOI: 10.1093/europace/eux286

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  QT prolongation predicts short-term mortality independent of comorbidity.

Authors:  Charlotte Gibbs; Jacob Thalamus; Doris Tove Kristoffersen; Martin Veel Svendsen; Øystein L Holla; Kristian Heldal; Kristina H Haugaa; Jan Hysing
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

2.  Relationship between resting 12-lead electrocardiogram and all-cause death in patients without structural heart disease: Shinken Database analysis.

Authors:  Naomi Hirota; Shinya Suzuki; Takuto Arita; Naoharu Yagi; Takayuki Otsuka; Mikio Kishi; Hiroaki Semba; Hiroto Kano; Shunsuke Matsuno; Yuko Kato; Tokuhisa Uejima; Yuji Oikawa; Minoru Matsuhama; Mitsuru Iida; Tatsuya Inoue; Junji Yajima; Takeshi Yamashita
Journal:  BMC Cardiovasc Disord       Date:  2021-02-10       Impact factor: 2.298

3.  Association Between Dynamic Change of QT Interval and Long-Term Cardiovascular Outcomes: A Prospective Cohort Study.

Authors:  Min Ye; Jing-Wei Zhang; Jia Liu; Ming Zhang; Feng-Juan Yao; Yun-Jiu Cheng
Journal:  Front Cardiovasc Med       Date:  2021-11-30

4.  Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis.

Authors:  Marijana Putnikovic; Zoe Jordan; Zachary Munn; Corey Borg; Michael Ward
Journal:  Drug Saf       Date:  2022-08-10       Impact factor: 5.228

5.  Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data.

Authors:  Steven T Simon; Divneet Mandair; Premanand Tiwari; Michael A Rosenberg
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-03-08       Impact factor: 2.457

6.  Genetic and Phenotypic Characterization of Community Hospital Patients With QT Prolongation.

Authors:  Charlotte Gibbs; Jacob Thalamus; Kristian Tveten; Øyvind L Busk; Jan Hysing; Kristina H Haugaa; Øystein L Holla
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

7.  Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?

Authors:  Seung-Hwa Lee; Myungsoo Park; Kyoung-Min Park; Hye-Bin Gwag; Jungchan Park; Jeayoun Kim; Gyu-Seong Choi; Suk-Koo Lee; Gaab Soo Kim
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.